Update Series (2021) Lesson 5: Urethral Cancer in Men

Now in its 40th installment, the AUA Update Series is renowned for delivering high-quality lessons to practicing urologists, fellows and residents. All content is developed in consultation with and edited by internationally recognized experts in urology, making the AUA Update Series the most professional and sought-after self-study program available. Improve your practice and patient care by staying abreast of the latest treatments and surgical techniques in urology. 

Target Audience

  • Urologist
  • Resident

Learning Objectives

At the conclusion of this continuing medical education activity, the participant will be able to describe the presentation and workup of urethral cancer in men as well as current treatment strategies and survival outcomes.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
Course opens: 
Course expires: 
Parent activity set: 

Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: The American Urological Association designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Learners: The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

Evidence-Based Content: It is the policy of the AUA to ensure that the content contained in this CME enduring material activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group for identification of conflicts of interest. The AUA COI Review Work Group, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor and/or AUA COI Review Work Group.
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

Individual authors’ disclosures are located with their articles in each issue of The Update Series.

Update Series Advisory Group

Benjamin Newell Breyer, MD, FACSNothing to disclose 
Michael S. Cookson, MD, MMHCTesoRx Pharma LLCConsultant or Advisor
Astellas Pharma, Inc.Consultant or Advisor
MerckConsultant or Advisor
Bayer Healthcare PharmaceuticalsConsultant or Advisor
Ferring PharmaceuticalsConsultant or Advisor
Myovant SciencesConsultant or Advisor
E. Ann Gormley, MDAmerican Board of Medical SubspecialtiesLeadership Position
Cheryl Taylore Lee, MDMerckConsultant or Advisor
Brian R. Matlaga, MD, MPHBoston ScientificConsultant or Advisor
John Patrick Mulhall, MDThe Journal of Sexual MedicineLeadership Position
VaultConsultant or Advisor
Curtis Nickel, MD, FRCSCNational Institutes of HealthScientific Study or Trial
Canadian Institute of Health ResearchScientific Study or Trial
RedLeaf MedicalScientific Study or Trial
MicroGenDxScientific Study or Trial
InmunotekScientific Study or Trial
ValensaScientific Study or Trial
TEVAConsultant or Advisor
Farr LaboratoriesConsultant or Advisor
Alivio TherapeuticsConsultant or Advisor
Seikagaku CorporationConsultant or Advisor
JT PharmaConsultant or Advisor
Craig Stuart Niederberger, MDAmerican Society for Reproductive MedicineLeadership Position
Ferring PharmaceuticalsScientific Study or Trial
J. Kellogg Parsons, MD, MHSDendronConsultant or Advisor
Boston ScientificConsultant or Advisor
Stacy T. Tanaka, MD, MS, FAAP, FACSCenters for Disease Control and Prevention (CDC)Scientific Study or Trial
Journal of UrologyHealth Publishing
J. Christian Winters, MDStimGuardConsultant or Advisor
Christopher S. Saigal, MDWiseCareConsultant or Advisor
CeevaConsultant or Advisor

Off-label or Unapproved Use of Drugs or Devices: The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Reproduction Permission: Reproduction of written materials developed for this AUA activity is prohibited without the written permission from individual authors and the American Urological Association.

Release date: January 2021
Expiration date: January 2024

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Non-Physician Participation
Please login or register to take this course.